Cepheid

Today, we recognize Sree Rajeswari as our monthly Associate Spotlight. Cepheid innovates world-class products, but our people are the reason we succeed. This recognition speaks to the unique perspectives and skills Sree brings daily to her work as a manager in Consumables Engineering. Join us in congratulating Sree!

Join us at the conference between 12-15th December in Cape Town, South Africa and attend our symposium to discover innovative models transforming healthcare delivery.

https://ow.ly/pGRT50Qg8GM

Visit Cepheid at Booth #48 during ICASA 2023 from Dec 4-9 in Harare, Zimbabwe. Join Prof. Lynn S Zijenah, Professor of Immunology at the University of Zimbabwe, Faculty of Medicine and Health Science, and Dr Kevin Martin, Clinical Research Fellow with The Health Research Unit Zimbabwe, during Cepheid Coffee Chats sessions.

Dr. Christina Muzny discusses novel molecular diagnostics for co-testing STIs and vaginal infections in
an on-demand webinar now available. View the webinar now at: https://event.on24.com/wcc/r/4419701/9569172A843C962AD3F565FDE3813EE2?partnerref=LI

Visit Cepheid at Booth #48 during ICASA 2023 from Dec 4-9 in Harare, Zimbabwe. Join Prof. Lynn S Zijenah, Professor of Immunology at the University of Zimbabwe, Faculty of Medicine and Health Science, and Dr Kevin Martin, Clinical Research Fellow with The Health Research Unit Zimbabwe, during Cepheid Coffee Chats sessions.

Improving the diagnosis of HIV is an essential step to increasing access to care. The Xpert® HIV-1 Viral Load test can detect HIV in 91 minutes.* Learn what Cepheid is doing to increase access to HIV testing worldwide: https://www.cepheid.com/en-GB/impact/global-access/hiv.html

*CE-IVD. In Vitro Diagnostic Medical Device. Not all tests available in all countries.

To mark World AIDS Day and advance the community-focused theme, Cepheid supports Shout It Now, a South African-based community organization that has dedicated itself to the fight against HIV in South Africa and to bring awareness to its critical work and advance its programmatic goals.

Learn how Shout It Now uses innovative approaches to reach communities with free sexual and reproductive health services.

Shout-It-Now Client Journey As a proudly South African organization, we design innovative approaches to reach communities with free sexual and reproductive health services. Modern, cust...

The world can end AIDS with communities leading the way. Communities connect people with public health services, build trust, innovate, monitor the implementation of policies and services and hold providers accountable. Cepheid supports UNAIDS and the mission to “Let Communities Lead.”

Learn more: https://www.unaids.org/en/2023-world-aids-day

Many of our colleagues around the globe celebrated Diwali this month. The Sunnyvale, Calif. campus enjoyed a special event with food, music, dance, and giveaways in honor of the Festival of Lights. Thank you to everyone who planned events and participated across the organization!

Cepheid commemorates World Aids Day 2023 and the UNAIDS theme this year, "Let Communities Lead." We remain steadfast in our commitment to enabling access to fast and reliable early detection for those affected by HIV.

Watch the Launch of the 2023 UNAIDS World AIDS Day report live stream: https://www.youtube.com/watch?v=VcobMl__bR0&t=0s

Discover more about UNAIDS’ work: https://www.unaids.org/en

The Cepheid Canada team proudly sponsored and participated at L'Ordre Professionnel des Technologistes Médicaux in Québec on November 3rd & 4th, 2023. After a three-year break due to the COVID-19 pandemic, this event was an excellent opportunity for Cepheid to again participate in the OPTMQ 2023 congress. It was a pleasure to connect with renowned experts, sharing and exchanging knowledge through various lectures, workshops, and interactive sessions.

Protect your patients and fight with antimicrobial and diagnostic stewardship programs in your hospital or health system. Download Frost and Sullivan’s Whitepaper on Antimicrobial and Diagnostic Stewardship to learn more:

https://ow.ly/rqVw50Qc8TM

World Vaccine Congress West Coast attendees, join us at booth #508 to learn how our GeneXpert® systems and high-performing PCR tests can help accelerate clinical trials with fast patient enrollment.

Superbug outbreaks and antimicrobial resistance (AMR) together pose one of the greatest challenges to health systems and national elective recovery plans. With the right test, quickly and accurately identify pathogens in under one hour to enable the correct isolation and treatment, keeping wards open, reducing hospital costs, and stopping the spread of resistance. This World AMR Awareness Week (WAAW), explore our brand-new dedicated AMR and stewardship resource, featuring the latest in webinars, impact publications, videos, tools, and solutions to help tackle AMR. Join us in the race - MORE results, LESS spread.

Let’s implement your antimicrobial screening and stewardship program today:
https://www.cepheid.com/en-US/impact/enhanced-antibiotic-stewardship.html

WHO SEA countries had the highest risk of emergence and spread of AMR among all WHO regions, with an estimated 486,000 deaths per year directly attributable to AMR and 3x more direct costs. This World AMR Awareness Week (WAAW), explore how on-demand PCR solutions optimize screening and stewardship policies, helping keep our antibiotics working and our patients safe.

Let’s implement your antimicrobial screening and stewardship program today:
https://www.cepheid.com/en-GB/impact/enhanced-antibiotic-stewardship.html

There are more than 670,000 antimicrobial-resistant infections annually in the EU/EEA. This World AMR Awareness Week (WAAW), explore how on-demand PCR solutions optimize screening and stewardship policies, helping keep our antibiotics working and our patients safe.

Let’s implement your antimicrobial screening and stewardship program today:
https://www.cepheid.com/en-GB/impact/enhanced-antibiotic-stewardship.html

There are more than 2.8 million cases of antimicrobial-resistant infections annually in the U.S. This World AMR Awareness Week (WAAW) explore how on-demand PCR solutions optimize screening and stewardship policies, helping keep our antibiotics working and our patients safe.

Let’s implement your antimicrobial screening and stewardship program today:
https://ow.ly/nx9B50Q8rnC

WEBINAR: The world is running out of antibiotics.* This World AMR Awareness Week, join our global panel as they share cross-regional expertise, including real-world lived experience of managing outbreaks, meta-analysis and novel diagnostic approaches in the fight against resistance and threat to last-line antibiotics.

* World Health Organisation (WHO). July 2022 Report: Antimicrobial Resistance. Accessed April 2023 https://ow.ly/hVgV50Q8pFa

• Dr. Stephen Brecher, The Challenging C’s of AMR: CPE, CDI & Candida
• Prof. David Jenkins, A Pragmatic Strategy to Tackling Antimicrobial Resistance in Hospitals
• Dr. Sanjay Bhattacharya, The Problems and Potential Solutions of Antimicrobial Resistance: A Perspective from a Cancer Hospital in Eastern India

Register Now: https://ow.ly/SJWS50Q91u9

In the global race against antimicrobial resistance (AMR) and related healthcare-associated infections, we provide diagnostic solutions that quickly and accurately identify pathogens and superbugs to enable the right isolation and treatment before it’s too late. This World AMR Awareness Week (WAAW), explore our brand-new dedicated AMR and stewardship resource, featuring the latest in webinars, publications, videos, tools, and solutions to help tackle AMR. Join us in the race - MORE results, LESS spread.

Let’s implement your antimicrobial screening and stewardship program today:

https://www.cepheid.com/en-US/impact/enhanced-antibiotic-stewardship.html

We are proud to collaborate with to enhance accessibility to sexual health testing solutions during the week of November 20 – 27, 2023.

World Vaccine Congress West Coast attendees, we invite you to visit us at booth #508 to learn how we can support your clinical trials worldwide. Our PCR technology provides quick, efficient, on-demand answers that accelerate patient recruitment and enrollment. Join us to learn how we can help you achieve your goals faster.

WEBINAR: The world is running out of antibiotics.* This World AMR Awareness Week, join our global panel as they share cross-regional expertise, including real-world lived experience of managing outbreaks, meta-analysis and novel diagnostic approaches in the fight against resistance and threat to last-line antibiotics.

* World Health Organisation (WHO). July 2022 Report: Antimicrobial Resistance. Accessed April 2023 https://ow.ly/hVgV50Q8pFa

• Dr. Stephen Brecher, The Challenging C’s of AMR: CPE, CDI & Candida
• Prof. David Jenkins, A Pragmatic Strategy to Tackling Antimicrobial Resistance in Hospitals
• Dr. Sanjay Bhattacharya, The Problems and Potential Solutions of Antimicrobial Resistance: A Perspective from a Cancer Hospital in Eastern India

Register Now: https://ow.ly/TnGc50Q8rB8?partnerref=LI1

You’re Invited! Cepheid’s symposium at on Lung Health 2023 takes place in Paris, France, Nov 16th,13:15 – 14:45 CET. Learn how equitable access and scale-up of WHO-recommended rapid diagnostics as the initial diagnostic test for presumptive TB and Drug Resistance Testing can enable fast diagnosis of drug-resistant TB and guide treatment decisions. ,

Cepheid is committed to patient-centered care. Join us in Paris, France, at the World Conference on Lung Health 2023 at booth B6333 on November 15-18 to learn how a significant reduction of TB incidence and elimination of HIV-associated TB deaths can be achieved by adopting and scaling up policies that ensure integrated, patient-centered prevention, early detection, and treatment” WHO

Learn more: https://ow.ly/uNXW50Q5a7P

attendees, please join us at Cepheid’s booth #1401 and attend our symposium on November 15, 2023, to learn how Cepheid’s Xpert® BCR-ABL Ultra decreases workflow complexity and hands-on time by automating the entire testing process, delivering fast results for leukemia patients.

Register now: https://amp23.amp.org/

Cepheid is committed to partnerships in the fight to . Join us at the on Lung Health, booth B6333 in Paris, France, November 15-18.

https://ow.ly/QmLl50Q59Bb

A Not-for-Profit in Vietnam Fights to End Tuberculosis In Hanoi, Vietnam, hear from Luan Vo, Co-Founder of Friends for International TB Relief, as he speaks about being a voice for vulnerable populations and the ...

Join us at the Union World Conference on Lung Health in Paris, France, November 15-18 in Booth B6333 to learn how Cepheid is committed to MORE access. Our Global Access Program, founded in 2011, provides to quality diagnostic tests to support goals, including the elimination of diseases such as Viral , , , and

https://www.cepheid.com/en-US/impact/global-access.html

Escuche el ejemplo de como un Hospital Canario usa técnicas de Biología Molecular para el control de las Resistencias Antimicrobianas, en el seminario virtual que celebraremos el 6 de noviembre a las 16:30 (Hora Canaria). Regístrese
ahora:

https://ow.ly/q78X50Q2lfu

WEBINAR: Antimicrobial resistance (AMR), including superbugs such as CPE, MRSA and VRE, remains some of the greatest challenges to healthcare systems
and patient outcomes alike. Join our expert global panel as we examine real-world lived experience, meta-analysis and novel approaches to managing the growing burden of AMR and the threat to last-line antibiotics.

• Dr. Roxanne Rule, Antimicrobial Resistance: The Extent of the Problem and Role of Rapid Diagnostics
• Joan Hebden, Carbapenemase-Producing Enterobacterales: Is it Time for Rapid Detection Surveillance Screening for Infection Prevention
• Prof. Vittorio Sambri, Decentralizing Microbiology Services for the Detection of Drug-resistant Pathogens: A Novel Hub & Spoke Model

Register Now: https://event.on24.com/wcc/r/4384129/998EC7521A1F9AA7B23925F1A42BC99D/5050333?partnerref=LI2

Cepheid's Black + Friends ARG Champion Network (BCN) hosted its 1st Summit last month at Cepheid's main campus in Sunnyvale, Calif. This event was a powerful opportunity for Black associates across Cepheid to connect in person, work on their career development, have meaningful discussions, and engage with Cepheid and Danaher senior leaders to influence change and foster a more inclusive workplace.

Our people are the reason we succeed from the corner office to the manufacturing floor. We unite to impact the lives of patients around the world. Today, we’re featuring our inspiring leaders, including our president, . We each apply insights, instill trust, and work as a team to drive continuous improvement and innovation inside and outside the organization.

Our Leadership Our leadership team pushes us to deliver "A Better Way" to improve patient outcomes by enabling access to molecular diagnostic testing to patients everywhere. Learn more about our leadership team.

Thrombophilia, which causes blood clots to form more frequently, often will not show any symptoms and is caused by a combination of acquired and genetic factors. Xpert® FII & FV can test for the most commonly associated genetic mutations, Factor II (FII) and Factor V (FV) alleles, in 30 minutes, simply by adding the blood sample to the cartridge.


https://ow.ly/R9ZW50PWHhZ

Join us Wednesday, October 25th at 11 am EDT to learn about how Cepheid’s multi-gene target PCR test for influenza provides confidence in an ever-changing world.

Register for the webinar now at: https://ow.ly/1y9W50PYJun

According to the World Health Organization, an estimated 70 million Africans (60 million with hepatitis B and 10 million with hepatitis C) suffer from chronic viral hepatitis. Cepheid is proud to participate in the groundbreaking Africa Hepatitis Summit in Abuja, Nigeria. Join our experts as they discuss the importance of simplifying the testing process with our Xpert® virology tests, which can test for B and C.

* Hepatitis | WHO | Regional Office for Africa

Learn more: https://www.cepheid.com/en/tests/Virology

WEBINAR: Antimicrobial resistance (AMR), including superbugs such as CPE, MRSA and VRE, remains one of the greatest challenges to healthcare systems and patient outcomes alike. Join our expert global panel as we examine real-world lived experience, meta-analysis and novel approaches to managing the growing burden of AMR and the threat to last-line antibiotics.

• Dr. Roxanne Rule, Antimicrobial Resistance: The Extent of the Problem and Role of Rapid Diagnostics
• Joan Hebden, Carbapenemase-Producing Enterobacterales: Is it Time for Rapid Detection Surveillance Screening for Infection Prevention
• Prof. Vittorio Sambri, Decentralizing Microbiology Services for the Detection of Drug-resistant Pathogens: A Novel Hub & Spoke Model

Register Now: https://ow.ly/Rlgg50PZbOI